3.14

4.85% -0.16

After Hours: 3.13 -0.01 -0.32%

Atea Pharmaceuticals Inc (AVIR)

Overview News Price History Option Chain Financials Discussions Forecast

Atea Pharmaceuticals Inc stock is traded at $3.14, with a volume of 182.10K. It is down -4.85% in the last 24 hours and down -10.54% over the past month. Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Previous Close:

$3.30

Open:

$3.29

24h Volume:

182.10K

Relative Volume:

0.52

Market Cap:

$249.18M

Revenue:

$351.37M

Net Income/Loss:

$-174.01M

P/E Ratio:

-1.5169

EPS:

-2.07

Net Cash Flow:

$-126.94M

1W Performance:

-6.82%

1M Performance:

-10.54%

6M Performance:

+1.29%

1Y Performance:

-14.44%

1-Day Range:

$3.10

$3.29

1-Week Range:

$3.095

$3.38

52-Week Range:

$2.455

$4.145

Atea Pharmaceuticals Inc Stock (AVIR) Company Profile

Name

Atea Pharmaceuticals Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

857-204-8109

Address

225 FRANKLIN STREET, BOSTON

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

AVIR's Discussions on Twitter

Compare AVIR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AVIR Atea Pharmaceuticals Inc	3.14	249.98M	351.37M	-174.01M	-126.94M	-2.07
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Aug-10-23	Downgrade	JP Morgan	Neutral → Underweight
Jan-06-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Nov-18-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Oct-20-21	Downgrade	JP Morgan	Overweight → Neutral
Oct-05-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-25-20	Initiated	Evercore ISI	Outperform
Nov-24-20	Initiated	JP Morgan	Overweight
Nov-24-20	Initiated	Morgan Stanley	Overweight
Nov-24-20	Initiated	William Blair	Outperform

View All

Atea Pharmaceuticals Inc Stock (AVIR) Latest News

Sep 12, 2025

Has Atea Pharmaceuticals Inc. formed a bullish divergence2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser

Sep 12, 2025

Price momentum metrics for Atea Pharmaceuticals Inc. explained2025 Price Action Summary & Low Drawdown Trading Strategies - Newser

Sep 12, 2025

Will Atea Pharmaceuticals Inc. continue its uptrend2025 Support & Resistance & Free Safe Capital Growth Stock Tips - Newser

Sep 12, 2025

Using AI based signals to follow Atea Pharmaceuticals Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser

Sep 12, 2025

News impact scoring models applied to Atea Pharmaceuticals Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 12, 2025

Is Atea Pharmaceuticals Inc. stock bottoming outJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser

Sep 12, 2025

Published on: 2025-09-12 16:19:18 - Newser

Sep 12, 2025

Applying Elliott Wave Theory to Atea Pharmaceuticals Inc.July 2025 Institutional & Intraday High Probability Alerts - Newser

Sep 12, 2025

Applying chart zones and confluence areas to Atea Pharmaceuticals Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - Newser

Sep 12, 2025

Short interest data insights for Atea Pharmaceuticals Inc.Earnings Miss & Risk Managed Trade Strategies - Newser

Sep 12, 2025

Volatility clustering patterns for Atea Pharmaceuticals Inc.Trade Volume Report & Free Technical Confirmation Trade Alerts - Newser

Sep 12, 2025

Will Atea Pharmaceuticals Inc. rebound enough to break evenWeekly Trend Report & Entry Point Strategy Guides - Newser

Sep 12, 2025

Should you hold or exit Atea Pharmaceuticals Inc. nowWeekly Earnings Recap & Weekly Top Gainers Trade List - Newser

Sep 12, 2025

Sep 11, 2025

Published on: 2025-09-11 05:04:19 - Newser

Sep 11, 2025

How sentiment analysis helps forecast Atea Pharmaceuticals Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - Newser

Sep 11, 2025

Multi factor analysis applied to Atea Pharmaceuticals Inc.Weekly Trade Report & Weekly Sector Rotation Insights - Newser

Sep 11, 2025

Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersMarket Performance Report & Expert Approved Momentum Trade Ideas - Newser

Sep 11, 2025

Sep 10, 2025

Intraday pattern recognizer results for Atea Pharmaceuticals Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - Newser

Sep 10, 2025

What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundForecast Cut & Technical Pattern Recognition Alerts - Newser

Sep 10, 2025

Tick level data insight on Atea Pharmaceuticals Inc. volatilityWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 10, 2025